Showing 2,621 - 2,640 results of 18,038 for search 'significantly ((((largest decrease) OR (teer decrease))) OR (((we decrease) OR (a decrease))))', query time: 0.77s Refine Results
  1. 2621
  2. 2622
  3. 2623
  4. 2624
  5. 2625

    Raw data. by Saeedeh Abbasi (9423189)

    Published 2025
    “…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …”
  6. 2626

    Data. by Saeedeh Abbasi (9423189)

    Published 2025
    “…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …”
  7. 2627

    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  8. 2628

    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  9. 2629

    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  10. 2630

    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  11. 2631
  12. 2632
  13. 2633
  14. 2634
  15. 2635
  16. 2636

    List of drug resistance gene. by Shuai Huang (60512)

    Published 2025
    “…Additionally, 16S rRNA species profiling revealed that the composting process significantly altered the microbial community structure, with an increased abundance of Firmicutes and a decreased abundance of Bacteroidetes in composted pig manure. …”
  17. 2637

    Serves as the data source for Figs 1 and 2. by Shuai Huang (60512)

    Published 2025
    “…Additionally, 16S rRNA species profiling revealed that the composting process significantly altered the microbial community structure, with an increased abundance of Firmicutes and a decreased abundance of Bacteroidetes in composted pig manure. …”
  18. 2638

    Primers sequences of drug resistance genes. by Shuai Huang (60512)

    Published 2025
    “…Additionally, 16S rRNA species profiling revealed that the composting process significantly altered the microbial community structure, with an increased abundance of Firmicutes and a decreased abundance of Bacteroidetes in composted pig manure. …”
  19. 2639

    Serves as the data source for Fig 3. by Shuai Huang (60512)

    Published 2025
    “…Additionally, 16S rRNA species profiling revealed that the composting process significantly altered the microbial community structure, with an increased abundance of Firmicutes and a decreased abundance of Bacteroidetes in composted pig manure. …”
  20. 2640

    Serves as the data source for Fig 4. by Shuai Huang (60512)

    Published 2025
    “…Additionally, 16S rRNA species profiling revealed that the composting process significantly altered the microbial community structure, with an increased abundance of Firmicutes and a decreased abundance of Bacteroidetes in composted pig manure. …”